The tissue specific transcription factor HNFla (LFBl) expressed in liver, kidney, stomach and gut gets transcriptionally activated in Xenop~.~ shortly after zygotic transcription starts. By microinjection into fertilized Xenopus eggs, a HNFla promoter fragment is activated in the middle part of developing larvae, reflecting the activation pattern of the endogenous HNFla gene. Mutational analysis of the HNFla promoter shows that HNFl and HNF4 binding sites are essential for proper embryonic regulation. Since by injecting HNF4 mRNA into fertilized eggs the endogenous HNFla gene is activated ectopically and HNW is present as a maternal protein within an animal to vegetal gradient in the embryo, we assume that HNF4 initiates a transcriptional hierarchy involved in determination of different cell fates.
Introduction
Diversity of cell types is established by differential gene expression that is mainly achieved at the transcriptional level by transcription factors interacting with regulatory elements in the promoters and enhancers of genes. Thus, each cell type is specified by a unique combination of tissue specific transcription factors.
In hepatocytes the tissue specific transcription factors include several members of the HNFl, HNF3 and C/EBP family, as well as HNF4, an orphan member of the nuclear receptor superfamily (for a review see Lai and Darnell, 1991; Tronche and Yaniv, 1992; Sladek and Darnell, 1992) . As the presence of HNFla (previously referred to as HNFl or LFBl ; see Tronche and Yaniv, 1992) and HNF4 closely correlates with the differentiation status of hepatoma cells (Cereghini et al., 1990; Griffo et al., 1993) , it is believed that these two transcription factors play the major role in hepatic differentiation.
However, both these transcription factors are also found in other tissues including kidney, stomach and intestine (Baumhueter et al., 1990; Kuo et al., 1990; Sladek et al., 1990; Blumenfeld et al., 1991) , and therefore it is assumed that they also participate in the differentiation of other cell types. The best evidence for this hypothesis is given so far for the HNF4 homolog in Drosophila where a large chromosomal deletion also containing the HNF4 locus leads to defects in structures equivalent to vertebrate liver, kidney and gut (Zhong et al., 1993) . However, it is not known whether defects in the HNF4 gene alone can produce the same abnormalities. In mammals no similar observations could be made, since the loss of the HNF4 gene leads to embryonic death prior to organogenesis .
Based on the fact that the HNFla promoter of rat, mouse and Xenopus contain a functional binding site for HNF4 (Tian and Schibler, 1991; Kuo et al., 1992; , it has been postulated that HNF4 is at the top of a ,@anscriptional hierarchy. However, it has recently been shown that the HNF4 promoter is also regulated by HNFla (Zhong et al., 1994; Taraviras et al., 1994) . Thus, the model of a transcriptional cascade may have to be replaced by the concept of a transcriptional network.
Nevertheless, we expect during early development some hierarchy that is initiated by maternal transcription factors and sets up a cell specific regulatory network. In fact, maternal transcription factors have been identified in the egg of several species: Whereas in Drosophila it has been established that such maternal transcription factors trigger the initiation of transcriptional cascades which establish the body plan (for a review see St Johnston and NiissleinVolhard, 1992) , similar conclusive data in vertebrates are lacking (for recent reviews see Gurdon, 1992; Dawid, 1994; Kessler and Melton, 1994; Slack, 1994) . As early development of Xenopus is an excellent model for vertebrate development and several maternal factors have been identified in this species (e.g. XLPOU-60, Whitfield et al., 1993; Xrel, Richardson et al., 1994; Bearer, 1994; B-myb, Bouwmeester et al., 1994) , we decided to identify the transcriptional cascade leading to HNFla activation during Xenopus development. In previous studies we have shown that the HNFla gene gets transcriptionally activated shortly after midblastula transition and thus is one of the first genes transcribed zygotically in the Xenopus embryo. Later in development HNFla can be detected in the embryonic liver, kidney, stomach and gut (Weber et al., 1995) , tissues that also express HNFla in the adult .
To identify the elements and factors activating HNFla gene transcription during development, we analyzed the function of the HNFla promoter. We found that upon injection of full length HNFla promoter CAT constructs into fertilized Xenopus eggs, correct expression in the middle part of a larvae containing the tissues expressing HNFla can be observed . The 5' and 3' borders of the v HNFla promoter crucial for the proper embryonic regulation contain the OZ element and the B transcription start site, respectively. The corresponding functional analysis of the rat HNFla promoter revealed that this mammalian promoter is also properly activated upon injection into fertilized Xenopus eggs and that at the 5' border an OZ element is essential for embryonic activation as well . These findings establish that the developmental activation of the HNPla gene has been conserved in vertebrates. The OZ element binds the maternal factor OZ-1 that was initially described to bind to elements within the promoter of the N-CAM and of the GS17 gene (Ovsenek et al., 1992) . As the N-CAM gene gets permanently activated in neural tissue (Kintner and Melton, 1987) and the GS17 gene is activated transiently in early development (Krieg and Melton, 1985) , both expression patterns differ from that of the HNFla gene. Therefore, we assume that OZ-1 binding alone is not sufficient for cell specific HNFla activation and that additional factors with a limited distribution are essential.
In this paper we reveal by mutational analysis that two HNFl binding sites and a HNF4 binding site are essential elements for a cell specific activation of the HNFla gene during early vertebrate development. We show that HNF4 is a maternal protein which is distributed in a gradient in early stages of embryogenesis. Thus, 'HNF4 is a potential initiator of a transcriptional cascade within a subset of cells committed to a specific developmental program in a vertebrate species.
Results

The HNFI and HNF4 binding sites of the HNFla promoter are essential for embryonic activation
Deletion analysis of the HNFla promoter has shown that the OZ element (-594 with respect to the ATG initiation codon) and the transcription B start site (-207) are the essential elements at the 5' and the 3' end of the promoter, respectively, to obtain, in Xenopus embryos, preferential activation of injected genes in the middle part that expresses endogenous HNFla . To prove that a promoter segment from -594 to -207 is sufficient for such a proper embryonic activation of the HNFla promoter, we injected the construct (-594/-207) into fertilized eggs and analyzed the activity in the dissected larvae 3 days later. As Fig. 1 demonstrates the activity of the injected promoter construct is approximately 25-fold higher in the middle part of the larvae compared to the head and tail. Therefore, we conclude that the region from -594 to -207 is the minimal HNFla promoter fragment mediating correct embryonic activation.
To define elements within the minimal HNFla promoter that contribute to the proper embryonic activation we introduced specific mutations into the HNF4 binding site, as HNF4 has been proposed as a major activator of HNFla in mammalian cell cultures (Tian and Schibler, 1991; Kuo et al., 1992; Zapp et al., 1993) . The HNF4 binding site was destroyed by introducing two different kind of mutations, leading to constructs that cannot be transactivated in transfection experiments by an expression vector encoding HNF4 (data not shown). Injecting these mutant HNFla promoter constructs into developing Xenopus eggs, we observed for both these constructs (-5941-207 h4 mutl and -5941-207 h4 mut2) an approximately fivefold reduction in expression in the middle part of the embryo compared to the wild type promoter (-597/-207), but still the activity was about fourfold higher in the middle part compared to head and tail (Fig. 1) . Therefore, we conclude that the HNF4 binding site supports the embryonic activation of the HNFla promoter, but the presence of other regulatory elements in the HNFla promoter is also essential for embryonic activation. As the closely spaced two HNFI binding sites at -523 and -497 are likely candidates, we introduced a specific mutation into these elements. Using the mutated HNFl binding sites in gel retardation experiments we confirmed that we have successfully destroyed these Zapp et al., 1993) . Mutated binding sites are marked by a cross. (B) The relative CAT activity of the various injected promoter constructs in the head, middle part and tail is given. The activity found in the tail was used as a reference and the values are the mean of more than 4 experiments with at least 15 injected embryos each.
binding sites (data not shown). Upon introduction of this mutated construct (-593/-207 hl mm) into developing Xenopus embryos we found a clear decrease in the activation of the injected promoter in the middle section of the embryo (Fig. 1) demonstrating that the HNFl binding sites in the HNFla promoter are also involved in the embryonic activation. By combining the HNFla promoter mutant -594/-207 h4 mutl with the HNFl mutant -594/ -207 hl mut, we generated a HNFla promoter construct (-5941-297 dm) containing both the HNF4 and HNFl sites mutated. Injecting this construct into eggs, we observed a complete loss of the preferential regional expression in the embryo (Fig. 1) .
Taken together the mutational analysis of the HNFla promoter shows that in addition to the OZ element previously shown to be absolutely required for embryonic activation , the binding sites for HNFl and HNF4 are both essential.
The role of the HNF4 binding site in the activation of the HNFla promoter was confirmed by injection of a construct containing the OZ element, the HNF4 binding site and the transcription start site. To obtain this construct the internal 271 bp of the construct -594/-207 containing the HNFl binding sites (Fig. 1) were deleted.
This construct is properly activated in Xenopus embryos and the activity depends completely on the integrity of the HNF4 binding site (data not shown).
HNF4 induces ectopic expression of HNFla in Xenopus embryos
To investigate in an independent approach whether HNF4 is a major factor in the embryonic activation of HNFla, we introduced HNF4 into fertilized Xenopus eggs and analyzed whether ectopic activation of the endogenous HNFla gene is induced. After injection of synthetic capped mRNA encoding rat HNF4 into fertilized eggs we observed that HNFla protein is present not only in the middle part of the larvae but also in the head and to a smaller extent in the tail (Fig. 2 , lanes 4-6) of larvae derived from injected eggs whereas in uninjected control larvae HNFla occurs exclusively in the middle part (Fig. 2 , lanes l-3) as reported previously . These experiments prove that rat HNF4 is able to activate the endogenous HNFla gene in the head and tail where it is normally not expressed and point to an important role of HNF4 during embryogenesis. 
Cloning and characterization of HNF4 of Xenobus
To analyze whether HNF4 is present at the right time and place in the embryo to be the endogenous inducer of HNFla, we cloned the cDNA encoding the HNF4 homologue of Xenopus to generate probes for analyzing developmental HNF4 expression. In Fig. 3A the amino acid sequences of Xenopus and rat HNF4 (Sladek et al., 1990 ) are compared whereas Fig. 3B summarizes the amino acid homology between different protein domains. It is evident that the zinc finger domain (C) representing the DNA binding region and the hinge domain (D) are absolutely conserved between the two species and that the hydrophobic region (E) that might interact with a ligand shows 87% identity. Relatively high conservation is also seen in the amino terminal part (A/B) and the carboxy terminal part (F) with 65% and 68% identity, respectively.
In gel retardation assays HNF4 from Xenopus liver extracts and in vitro translated Xenopus HNF4 form identical complexes with labeled HNF4 binding sites, which can be specifically retarded using a HNF4 specific antibody (data not shown). These binding data establish that we have cloned the HNF4 protein found in Xenopus liver. Since an expression vector encoding Xenopus HNF4 is able to transactivate a reporter construct containing HNF4 binding sites in transient transfections (data not shown), we conclude that the cloned Xenopus HNF4 is a functional transcription factor.
The presence and accumulation of the HNF4 mRNA and HNF4 protein during Xenopus embryogenesis
To determine the developmental expression of HNF4 we quantitated HNF4 mRNA by an RNase protection assay using RNA derived from various stages of development. As shown in Fig. 4A HNF4 transcripts are absent in the two cell stage (stage 2), early (stage 5) and late blastula (stage 8) but transcripts become detectable in the early gastrula (stage 10) when zygotic transcription has started, and accumulate dramatically during further development. From tailbud stage (stage 29) onwards, the level of HNF4 expression stays high until the latest stage analyzed. By whole-mount in situ hybridization we located the HNF4 mRNA in the hatched larvae (stage 38) in the pronephros, liver and gut (Fig. 4B top) , tissues where it is expressed in the adult frog (Holewa et al., unpublished), whereas a control larvae which was hybridized with a sense probe shows no such staining (Fig. 4B bottom) . The staining within the pronephros could already be detected from stage 29 onwards (data not shown), where the high increase in HNF4 mRNA levels can be observed in the RNase protection assay. At earlier stages of development, where only small amounts of HNF4 mRNA are detectable, we could not localize these transcripts in the embryos.
As the relatively late appearance of HNF4 mRNA during Xenopus development would argue against our assumption that HNF4 plays a major role in HNFla induction, it was critical to measure HNF4 on the protein (Sladek et al., 1990) . The DNA binding domain and the potential dimerizationfligand binding domain are shown in grey boxes whereas the eight conserved cysteins of the zinc finger are underlined. (B) The protein domains of HNF4 are schematically drawn as defined by Sladek et al. (1990) and are compared between the Xenopus and rat protein using HIBIO DNASIS. The amino acid identity is given for these domains. The nucleotide sequence of the Xenopus HNF4 has been deposited in the EMBL data bank (accession no. 237526).
level. We therefore generated monoclonal and polyclonal antibodies against the amino terminal part of Xenopus HNF4. Using the monoclonal antibody XH4 in Western blots of protein extracts of various developmental stages we detect HNF4 protein throughout the entire development (Fig. 5, lanes l-l 1) and the electrophoretic mobility of this protein corresponds to that of the liver protein (Fig. 5, lanes 12, 13 ). An identical result was obtained using a polyclonal rabbit antiserum against Xenopus HNF4 (data not shown). Therefore, we conclude that HNF4 is a maternal protein in Xenopus. In fact, HNF4 protein accumulates in growing oocytes as seen in Western blots (data not shown).
To localize maternal HNF4 protein in early embryonic stages we performed whole-mount immunostaining using albino embryos of various developmental stages. In an 8-cell embryo (Fig. 6A ), HNF4 specific staining is preferentially located in the smaller cells that represent the animal part of the embryo. A similar gradient in HNF4 protein distribution is observed in embryos of the 64-cell stage (Fig. 6B) . By making these same embryos transparent (Fig. 6C ) we reveal that, at this time point, a proportion of the HNF4 protein gets translocated into the nuclei. To verify that the absence of HNF4 in vegetal cells is not due to inaccessability of these cells for the antibody, we performed immunofluorescence on sections of blastula stage embryos (Fig. 7) . There is a clear animal to vegetal gradient of HNF4 positive nuclei, confirming the data obtained with the whole mount technique. The absence of HNF4 in vegetal cells can also be observed in late gastrula stages where no HNF4 specific staining is obtained in the yolk plug (Fig. 6D arrow) . The presence of maternal HNF4 in whole mount immuno stainings was also verified by an independent polyclonal antiserum raised against domain F, a different part of the HNF4 protein (data not shown). As we obtained identical localization of HNF4 using this antiserum, we have further evidence for the specificity of our antibodies.
Discussion
The HNFlapromoter elements essential for embryonic activation
We have previously documented that the OZ element binding the maternal factor OZ-1 and the transcription start site are absolutely required for the initial activation of the HNFla constructs . More importantly we show now that the binding sites of HNFI and HNF4 are both needed for full activation (Fig. 1) .
Concerning the factors interacting with the HNFl binding sites we assume that either HNFla itself acts via this sequence in an autoregulatory mode or that the related transcription factor HNFlp, previously referred to also as vHNF1 or LFB3 and showing the same DNA binding specificity as HNFla (De Simone et al., 1991; Mendel et al., 1991) recognizes these sites. From our own analysis we know that significant amounts of HNFla and 8 represents 2-cell, 16-cell and 132-cell embryos, respectively. Stage 10 is an early gastrula embryo and stage 13, 18 and 21 are neurula stages whereas stage 29 is a tailbud embryo. Stages 36 and 42 represent swimming larvae. The autoradiogram was overexposed to visualize the small amounts of HNF4 mRNA in early embryonic stages. The lower part shows an RNase protection experiment using a probe for the omithine decarboxylase mRNA (ODC). Since the amount of this RNA is stable during Xenopus development, this experiment was used as a control for the RNA. (B) A larvae from stage 38 which was stained by whole-mount in situ hybridization using a Xenopus HNF4 antisense RNA probe is shown at the top. Cells containing HNF4 RNA present in the pronephros (arrowhead) liver and gut (arrow) am stained blue. A control larvae hybridized with a sense probe is shown at the bottom protein appear quite late in the hatched larvae (stage 35 in Bartkowski et al., 1993) and thus is unlikely to contribute significantly to the activity of the HNFla promoter in early embryogenesis.
In contrast the HNFl/? mRNA accumulates to high levels at early stages in Xenopus embryogenesis in the endoderm (Demartis et al., 1994) and the protein can be detected already in the late blastula at stage 9 (Pogge v. Strandmann et al., unpublished) . Therefore, HNFl/? might contribute significantly to the activity of the HNFla promoter during embryogenesis.
Our promoter analysis establishes that in addition to the HNFl binding sites, the binding site for the orphan nuclear receptor HNW plays a major role for transcriptional activation of HNFla (Fig. 1). 
A transcriptional cascade is initiated by HNF4 in early embryogenesis
The evidence that HNF4 is a key regulator in HNFla gene activation is supported by our observation that HNF4 (Fig. 4B) and HNFla (Weber et al., 1995) colocalize in pronephros, liver and gut during development and that ectopically expressed HNF4 activates the endogenous HNFla genes in parts of the embryo that normally do not express HNFla (Fig. 2) Leibham et al., 1994 ) and transgenic mice (e.g. Pit-l, Rhodes et al., 1993; myogenin, Yee and Rigby, 1993) proper embryonic expression of promoters of genes encoding transcription factors has been observed, the factors involved in vivo for embryonic activation have not been identified in these systems. In addition the introduction of a specific transcription factor has been used in none of these cases to verify that such a factor can activate the corresponding endogenous gene. Furthermore, as HNF4 is a maternal transcription factor in Xenopus (see below), we assume that HNF4 is at the top of a transcriptional cascade involved in early embryogenesis.
It is most notable that the HNF4 injected Xenopus larvae, that contain HNFla in the head and tail are frequently morphologically normal. This agrees with the experiments in which we injected HNFla mRNA into fertilized eggs and obtained normal larvae with HNFla protein in the head and tail (Pogge v. Strandmann et al., unpublished data) . This is in contrast to the injection of mRNA encoding the transcription factor goosecoid (Cho et al., 1991) and B-myb (Bouwmeester et al., 1994 ) that lead to consistent defects in the developing embryos. Therefore, we assume that neither HNF4 nor HNFla are sufficient for morphological alteration of embryogenesis.
HNF4 is a maternal factor in Xenopus
We have established that HNF4 is a maternal transcription factor in Xenopus (Fig. 5) . Although the presence of maternal transcription factors in Xenopus has been established in numerous investigations (e.g. XLPOU-60, Whitfield et al., 1993; Xrel, Richardson et al., 1994; Bearer 1994; B-myb, Bouwmeester et al., 1994) , in contrast to HNF4 no well-defined transcriptional function of these factors during embryogenesis have been documented so far in any of these cases.
The recent analysis of the Drosophila homologue of HNF4 revealed that the mRNA encoding HNF4 is a maternal component of the egg (Zhong et al., 1993) . Assuming that the HNF4 protein is also present in the egg, we speculate that the maternal function of HNF4 has been conserved between Drosophila and Xenopus. This conservation also seems to include the effects of HNF4, since the deletion of the chromosomal region spanning the HNF4 gene leads in Drosophila to defects in organs homologous to vertebrate liver, kidney and gut, the tissues expressing HNF4 in Xenopus (Fig. 4B and unpublished data) and in mammals (Sladek et al., 1990; Taraviras et al., 1994; Zhong et al., 1994) .
In contrast there are no data yet available on whether HNF4 protein is a maternal transcription factor in mammals. However, the early developmental function of HNF4 has been documented recently by homozygous deletion of the gene in mice . In such animals cell death occurs in the embryonic ectoderm at day 6.5 together with an abnormal and delayed gastrulation. Analyzing the embryonic expression of HNF4 in the mouse, HNF4 mRNA has been detected already during implantation on day 4.5 p.c., a time point well before gastrulation and clearly preceding the appearance of HNFla on day 9.5 p.c. (De Simone et al., 1991) . Therefore, it is conceivable that in mammalian embryogenesis HNF4 is also controlling HNFla expres- Protein extracts from the indicated developmental stages were analyzed in a Western blot using the monoclonal antibody XH4 specific for HNF4. The migration of a molecular weight marker is given on the left side. In lanes 12 and .I3 the comigration of HNF4 from stage 41 larvae and from adult liver is shown. sion. In fact, such a hierarchy has been proposed based on transfection experiments in dedifferentiated hepatoma cell culture (Kuo et al., 1992) .
The absence of HNF4 mRNA in early stages of Xenopus (Fig. 4A ) apparently contradicts the presence of HNF4 protein in these stages. This discrepancy may be explained by the presence of very low amounts of HNW mRNA that are sufficient to provide the amount of maternal HNF4 during Xenopus oogenesis that takes several months. Alternatively, we assume that HNF4 mRNA is degraded during some stage of oogenesis and therefore is absent in the egg. Furthermore, we consider the possibility that HNF4 might be transported from outside into the growing oocyte. Such an explanation has been proposed for activin and follistatin, two maternal proteins in Xenopus whose mRNA are absent in the egg (for reviews see Dawid, 1994; Kessler and Melton, 1994; Slack, 1994) . The speculation that maternal factors of Xenopus eggs might be derived from an exogenous source, is supported by the findings in Drosophila where the follicle cells are known to provide several maternal components for the early development (reviewed in St Johnston and Ntisslein-Volhard, 1992).
The significance of the HNF4 gradient for embryogenesis
Using whole mount immunostaining (Fig. 6 ) as well as immunofluorescence on sections (Fig. 7) , we detected an animal to vegetal concentration gradient of HNF4 protein. So far, this is just documented for the maternal transcription factor Xrel (Baerer, 1994) and some mRNAs. These include RNAs encoding the Vg-I and Wnt-1 1 growth factors and the nanos-like RNA binding protein X-cat2 (reviewed in Dawid, 1994; Kessler and Melton, 1994; Slack, 1994) but also the transcript of the gene coding for the transcription factor XLPOU-60 (Whitfield et al., 1993) .
As HNF4 protein gradually accumulates during late cleavage stages in the nuclei of the animal blastomeres (Fig. 6C) , we assume that it functions as a transcription factor at midblastula transition when transcription in the Xenopus embryo is initiated. A similar nuclear accumulation of factors involved in transcription has been reported recently for Xrel (Bearer, 1994) and XDCoH, the cofactor of HNFla (Pogge v. .
The fact that the maternal transcription factor HNF4 is concentrated in the animal blastomeres of early cleavage stages (Fig. 7) implies that HNF4 might be an important determinant for generating asymmetry in early Xenopus development. We assume that this HNF4 concentration gradient is involved in the determination of the fate map of the various regions of the embryo and acts together with components that are either established maternally or during early development.
HNFla is induced during embryogenesis in the pronephros as well as in the liver and gut and therefore the induction occurs in mesoderma1 as well as endodermal tissues. Clearly, the distribution of maternal HNF4 is not restricted to the regions that will develop to tissues containing HNFla. Most strikingly is the localization of HNF4 in the animal hemisphere that represents the prospective ectoderm. Immunostaining of HNF4 in hatched larvae reveals HNF4 in the epidermis of the embryonic larvae (data not shown), an ectodermally derived tissue, where no HNFla is detectable (Weber et al., 1995) . Consistent with this observation in Xenopus the presence of HNF4 in the mouse skin has been reported recently (Taraviras et al., 1994) . These data show that HNF4 is also present in an ectodermally derived mammalian tissue that lacks HNFla expression. We assume therefore that in these tissues a set of genes are regulated by HNF4 that are not yet defined. On the other hand, some maternal HNF4 is present in the equatorial region that constitutes the prospective mesoderm including the pronephros. Therefore in this region HNF4 might directly trigger the expression of HNFla in the pronephros. In the endodermal region the mapping of HNF4 in albinos is not precise enough, and therefore we cannot deduce whether the region giving rise to liver and gut contains HNW.
Evaluating the significance of the gradient in early embryos one should consider that HNF4 as a member of the orphan receptor superfamily may have a ligand (Sladek et al., 1990; Sladek, 1994) . A potential ligand might profoundly influence the action of HNF4 and thus might act as an embryonic morphogen.
We assume that the HNF4 gradient present as a maternal determinant in the developing embryo cooperates with gradients of other embryonic components including those that represent the various mesoderm inducing factors known to be essential for embryonic inductions (for reviews see Dawid, 1994; Kessler and Melton, 1994; Slack, 1994) . It will be a major challenge to identify the connections between the gradient of the transcription factor HNF4 with the fields of the various embryonic growth factors.
Experimental procedures
I. Plasmid construction
The Xenopus HNFla promoter construct -5941-207 was cloned in the plasmid pEU-CAT (Piaggio and De Simone, 1990) by combining the constructs 5A594 and 3A207 , which contain HNFla promoter sequences from position -594 to -57 and -743 to -207 with respect to the initiator methionine, respectively, using the EcoRI site at -493.
The reporter plasmid -594/-207 h4 mutl and -594/ -207 h4 mut2 were constructed by mutagenesis of the HNF4 binding site within the construct -594/-207 using the Transformer Site-Directed Mutagenesis Kit (Clontech) as recommended by the manufacturer. The mutagenic primer spanning the HNF4 binding site was synthesized containing wobble bases at 5 positions. Sequencing was used to define the mutated constructs. Whereas the non-mutagenized HNF4 binding site has the sequence 5'-GTCCAAAGTTCAGT-3', in the construct -5941-207 h4 mutl this site was mutated to 5'-GTCAACACTmGT-3' and in the construct -594/-207 h4 mut2 the sequence was 5'-GTCGAcAcACTTmGT-3'.
To obtain the construct -594/-207 hl mut both HNFl binding sites within the wild type promoter (-594/-207) with the sequence 5'-AGGTTACTGTGTAVI'GlllTGG-
TAZT'CAG-3'
(italic letters indicate the HNFl binding sites) were mutated to 5'-AGG~ACTGTGTAllTGTTT-TGGTAGGAACAG-3' using the Transformer SiteDirected Mutagenesis Kit.
The expression vector coding for Xenopus HNF4 (XHNF41CMV) was constructed by inserting a fragment of the Xenopus HNF4 cDNA into the vector RcCMV (Invitrogen) using a Hind111 site 14 bp upstream and a .SpeI site about 2.2 kb downstream of the initiator methionine.
Injection of synthetic HNF4 mRNA and HNFIa promoter constructs into Xenopus eggs
The cDNA encoding the rat HNF4 gene (kindly provided by J.E. Darnell) inserted in the expression vector RcCMV ) was used as a template for 'I7 polymerase driven in vitro transcription. Synthetic HNF4 mRNA (500 pg) was injected into fertilized Xenopus eggs which were allowed to develop until stage 41. Larvae from injected embryos were dissected into head, middle part and tail, and HNFla was detected by Western blotting as described previously . Injection of HNFla promoter constructs and CAT assays were performed as described .
Isolation of Xenopus HNF4 cDNA clones
A randomly primed cDNA library of Xenopus liver was used for hybridization with the entire coding region of the rat HNF4 gene. The construction of the library and conditions used for the hybridization procedure were described previously . The inserts from positive clones were subcloned into the Bluescript II SK+ vector (Stratagene) and sequenced using an ALF sequencer (Pharmacia).
Computer analysis of the sequences were carried out with the HIBIO DNASIS program. The sequence of the Xenopus HNF4 cDNA has been deposited in the EMBL data bank (accession no. 237526).
RNase protection analysis and whole mount in situ hybridization
RNA derived from different developmental stages of Xenopus was prepared as described ). An antisense probe was synthesized covering 116 bp of the coding sequence (spanning base +lOOO to +l 115 of the coding region) and 43 bp of polylinker sequences with T7 RNA polymerase using the RNA synthesis kit (Clontech). RNase protection was carried out using 1OOpg of RNA as described by Sambrook et al. (1989) .
Whole mount in situ hybridization was according to Harland et al. (1991) , except the alkaline phosphatase reaction was carried out overnight at 4°C without shaking. Staging of the embryos was based on the criteria given by Nieuwkoop and Faber (1975) .
Production of Xenopus HNF4 specific antibodies and antiserum
A 396 bp fragment of the Xenopus HNF4 cDNA was amplified by PCR using specific primer with linker carrying restriction sites for SphI and BgZII. This fragment encoding the 132 N-terminal aa of HNF4 was inserted into the prokaryotic expression vector pQE30 (Diagen) using the SphI site creating a fusion protein with 6 histidine residues at the N-terminus. The protein was purified as recommended by the manufacturer and used by Eurogentee to immunize rabbits following their standard protocol. Monoclonal antibodies were prepared by immunization of (Balb/c) mice with 5Opg protein and boostered three times with 50,ug as described . The monoclonal antibody RH4 was raised against recombinant rat HNF4 (Stumpf et al., 1995) according to the same protocol.
For whole mount immunostaining the Xenopus HNF4 specific antiserum was affinity purified using the His tagged fusion protein covalently coupled to seryl activated agarose beads (1 mg/ml). The antiserum was eluted with 100 mM glycine (pH 2.5).
Western blotting
Extracts from whole embryos were prepared 4 times more concentrated than described by Bartkowski et al. (1993) and equivalents of one embryo were separated on a 10% SDS gel and electrotransferred to a nitrocellulose membrane (Sambrook et al., 1989) . The blots were incubated overnight with a sevenfold diluted hybridoma supernatant specific for Xenopus HNF4. Horseradish peroxidase-conjugated rabbit antibodies against mouse immunglobulin G were used to visualize bound HNF4 with the ECL-system (Amersham).
Whole mount immunostaining and immunohistochemistry
The immunostaining was performed as described by Hemmati-Brivanlou and Harland (1989) , except an alkaline phosphatase coupled anti-rabbit IgG mouse antibody (Boehringer, 250 fold diluted) was used to visualize bound Xenopus HNF4 specific antibodies (IO-fold diluted affinity purified polyclonal antiserum). The alkaline phosphatase reaction was carried out as recommended by Boehringer. ImmunohistochCmistry was as described previously except for the fixation of the embryos which was performed in MEMFA (0.1 M MOPS, pH 7.4, 2 mM EGTA, 1 mM MgS04 and 37% formaldehyde) by incubating for 2 h at room temperature and overnight at 4°C in MEMFAbuffer without formaldehyde containing 30% sucrose. The Xenopus HNF4 specific polyclonal antiserum was purified using protein A agarose (Boehringer) as recommended and was used for immunohistochemistry in a 200-fold dilution.
